Invesaro

Stocks MGA Financial statements

Financial statements

MAGNA INTERNATIONAL INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MAGNA INTERNATIONAL INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue36,44538,94640,82739,43132,64736,24237,84042,79742,83642,010
Cost of revenue31,12330,89535,05534,02228,20731,09733,18837,18537,03736,021
Gross profit5,3228,0515,7725,4094,4405,1454,6525,6125,7995,989
Research and development460522588640830634649862874792
Selling, general and administrative1,6011,6681,6641,6971,5871,7171,6602,0502,0612,221
Interest expense10090113104105122126242309275
Other non-operating income-30-39-63-240-584-38-703-388-464-736
Pre-tax income2,7802,9852,9512,2231,0061,9488781,6061,5421,308
Income tax706741619591329395237320446425
Income from continuing operations2,0742,255
Net income to minority interests434836-133-803949738754
Net income2,0312,1962,2961,7657571,5145921,2131,009829
EPS, basic5.195.916.655.612.525.042.044.243.522.94
EPS, diluted5.165.876.615.592.525.002.034.233.522.93
Shares, basic (weighted)391372345315300301290286287282
Shares, diluted (weighted)393374348316300303291287287283
Dividend per share1.001.101.321.461.601.721.801.841.901.94

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents9747266841,2763,2682,9481,2341,1981,2471,612
Receivables6,1656,6956,5485,9276,3946,3076,7917,8817,3767,593
Inventory2,8043,5423,4033,3043,4443,9694,1804,6064,1514,126
Other current assets220237193238260278320352344407
Total current assets10,16311,20011,83410,74513,36613,50212,52514,03713,11813,738
Property, plant and equipment7,0228,1768,0958,2608,4758,2938,1739,6189,5849,507
Lease right-of-use assets1,8111,9061,7001,5951,7441,9411,928
Goodwill1,9232,0991,9791,9762,0952,1222,0312,7672,6742,512
Intangible assets621650560484481493452876738490
Long-term investments1,8502,0792,1891,2109471,5931,4291,2731,0451,103
Other non-current assets7191,0269889969639621,0931,3191,1201,275
Total assets22,56625,46825,94525,79028,60529,08627,78932,25531,03931,417
Accounts payable5,4306,2836,0945,6286,2666,4656,9997,8427,1946,895
Accrued liabilities768836769753815851850912867888
Deferred revenue0176199214273347570301454
Short-term debt13910820110612945565481970827
Total current liabilities8,6959,24310,3048,5299,74310,40110,99813,23412,09710,989
Long-term debt2,3943,1953,0843,0623,9733,5382,8474,1754,1344,685
Lease liabilities1,6011,6561,4061,2881,3191,6621,649
Other non-current liabilities298326400371332376461475396399
Total liabilities12,34713,75614,78614,65916,88516,86116,45419,97819,09918,578
Total debt2,5333,3033,2853,1684,1023,9933,5014,9944,8424,712
Paid-in capital105119120127128102111125149142
Retained earnings7,3188,0748,3768,5968,7049,2318,6399,3039,5989,765
Other comprehensive income-1,451-600-1,175-1,090-733-900-1,114-898-1,584-766
Shareholders' equity9,76811,21010,70110,83111,37011,83610,93511,88411,52212,493
Minority interests451502458300350389400393418346
Total equity10,21911,71511,13411,13111,72012,22511,33512,27711,94012,839
Total liabilities and equity22,56625,46825,94525,79028,60529,08627,78932,25531,03931,417

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income2,0742,2442,3321,6326771,5536411,2861,096883
Depreciation and amortization1,0561,1841,2781,3451,3661,5121,3731,4361,5101,547
Deferred income tax20-628717-76-220-261-110-41
Change in receivables-446-292-351629-42114-798-819454835
Change in inventory-159-397-9210437-653-448-196153248
Change in payables562512265-519274160812609-357-697
Cash from operations3,2663,3463,7183,9603,2782,9402,0953,1493,6343,598
Capital expenditures-1,807-1,875-1,650-1,441-1,145-1,372-1,681-2,500-2,178-1,313
Acquisitions-1,810-148-147-3-1,504-86-1
Purchases of investments-220
Cash from investing-3,957-2,145-2,276-434-1,400-2,283-2,038-4,503-2,592-1,700
Debt issued2827521724785455542,0837781,048
Debt repaid-417-110-171-149-140-121-456-644-815-1,397
Share buybacks-904-1,271-1,831-1,289-203-517-780-13-207-137
Dividends paid-385-400-448-449-467-514-514-522-539-544
Cash from financing-1,020-1,554-1,443-2,94781-1,106-1,7331,337-989-1,532
Exchange rate effect1624-36112323-38-19-4-1
Net change in cash-1,695-329-375901,982-426-1,714-3649365
Free cash flow1,4591,4712,0682,5192,1331,5684146491,4562,285
Interest paid9988115103104122128242309270
Income taxes paid707782665484336341560546499610

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $65.00 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin14.3%Gross profit / revenue.
Pre-tax margin3.1%Pre-tax income / revenue.
Net margin2.0%Net income / revenue.
FCF margin5.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin8.6%Cash from operations / revenue.
Effective tax rate32.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)6.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)2.7%Net income / average total assets.
R&D / revenue1.9%Research and development expense / revenue.
SG&A / revenue5.3%Selling, general and administrative expense / revenue.
Capex / revenue3.1%Capital expenditures / revenue.
D&A / revenue3.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-1.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y3.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y5.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y3.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y8.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y6.2%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-17.8%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y11.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y1.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-16.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y13.0%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y3.1%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-1.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y19.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y1.9%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y56.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y76.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y1.4%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y2.1%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y2.5%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y3.9%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y8.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y4.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y1.9%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y1.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y4.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y1.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.25xCurrent assets / current liabilities.
Quick ratio0.84x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.15x(Cash + short-term investments) / current liabilities.
Debt / equity0.38xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets15.0%Total debt / total assets.
Liabilities / assets59.1%Total liabilities / total assets.
Net debt$3.10BTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$2.75BCurrent assets - current liabilities.
Goodwill and intangibles / assets9.6%(Goodwill + intangible assets) / total assets.
Tangible book value$9.49BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.35xRevenue / average total assets.
Fixed asset turnover4.40xRevenue / average property, plant and equipment.
Inventory turnover8.70xCost of revenue / average inventory.
Days inventory42 days365 x average inventory / cost of revenue.
Receivables turnover5.61xRevenue / average receivables.
Days sales outstanding65 days365 x average receivables / revenue.
Days payables71 days365 x average accounts payable / cost of revenue.
Cash conversion cycle36 daysDays inventory + days sales outstanding - days payables.
FCF conversion275.6%Free cash flow / net income, when net income is positive.
Capex / operating cash flow36.5%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.93Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$2.94Net income per basic share, as reported (split-adjusted).
Revenue per share$148.71Revenue / diluted weighted shares.
FCF per share$8.09Free cash flow / diluted weighted shares.
Operating cash flow per share$12.74Cash from operations / diluted weighted shares.
Book value per share$44.22Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$33.60Tangible book value / shares outstanding.
Cash per share$5.71(Cash + short-term investments) / shares outstanding.
Dividend per share$1.94Dividend declared per common share (paid, when declared is not tagged).
Payout ratio65.6%Dividends paid / net income, when net income is positive.
Dividends / FCF23.8%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF6.0%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$17.25BShare price x shares outstanding.
Enterprise value$20.35BMarket cap + total debt - cash - short-term investments.
P/E20.8xMarket cap / net income. Only when net income is positive.
P/S0.41xMarket cap / revenue.
P/B1.38xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.82xMarket cap / tangible book value, when positive.
P/FCF7.55xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF4.80xMarket cap / cash from operations, when positive.
EV/Sales0.48xEnterprise value / revenue.
EV/FCF8.91xEnterprise value / free cash flow, when both are positive.
FCF yield13.2%Free cash flow / market cap.
Earnings yield4.8%Net income / market cap (the inverse of P/E).
Dividend yield3.2%Dividends paid over the period / market cap.
Shareholder yield3.9%(Dividends paid + share buybacks) / market cap.
PEG1.60xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was MAGNA INTERNATIONAL INC's revenue in fiscal 2025?

MAGNA INTERNATIONAL INC reported revenue of $42.01B for fiscal 2025, 1.9% lower than the year before.

Was MAGNA INTERNATIONAL INC profitable in fiscal 2025?

Yes. Net income was $829.0M, a net margin of 2%.

How much free cash flow did MAGNA INTERNATIONAL INC generate in fiscal 2025?

Cash from operations of $3.60B minus capital expenditures of $1.31B left free cash flow of $2.29B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MAGNA INTERNATIONAL INC